Your browser doesn't support javascript.
loading
Whole-genome sequencing of asian lung cancers: second-hand smoke unlikely to be responsible for higher incidence of lung cancer among Asian never-smokers.
Krishnan, Vidhya G; Ebert, Philip J; Ting, Jason C; Lim, Elaine; Wong, Swee-Seong; Teo, Audrey S M; Yue, Yong G; Chua, Hui-Hoon; Ma, Xiwen; Loh, Gary S L; Lin, Yuhao; Tan, Joanna H J; Yu, Kun; Zhang, Shenli; Reinhard, Christoph; Tan, Daniel S W; Peters, Brock A; Lincoln, Stephen E; Ballinger, Dennis G; Laramie, Jason M; Nilsen, Geoffrey B; Barber, Thomas D; Tan, Patrick; Hillmer, Axel M; Ng, Pauline C.
Afiliação
  • Krishnan VG; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
  • Ebert PJ; Lilly Corporate Center, Indianapolis, Indiana.
  • Ting JC; Lilly Corporate Center, Indianapolis, Indiana.
  • Lim E; Medical Oncology, Mount Elizabeth Medical Centre, Mount Elizabeth, Singapore. Medical Oncology, Tan Tock Seng Hospital, Singapore, Singapore; Medical Oncology, National University Hospital, Singapore, Singapore;
  • Wong SS; Lilly Corporate Center, Indianapolis, Indiana.
  • Teo AS; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
  • Yue YG; Lilly Corporate Center, Indianapolis, Indiana.
  • Chua HH; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
  • Ma X; Lilly Corporate Center, Indianapolis, Indiana.
  • Loh GS; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore.
  • Lin Y; Lilly Corporate Center, Indianapolis, Indiana.
  • Tan JH; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore. ngpc4@gis.a-star.edu.sg tanbop@gis.a-star.edu.sg hillmer@gis.a-star.edu.sg.
  • Yu K; Lilly Corporate Center, Indianapolis, Indiana.
  • Zhang S; Genomic Oncology, Duke-NUS Graduate Medical School, Singapore, Singapore.
  • Reinhard C; Lilly Corporate Center, Indianapolis, Indiana.
  • Tan DS; Department of Medical Oncology, National Cancer Centre Singapore, Singapore, Singapore.
  • Peters BA; Complete Genomics, Inc., Mountain View, California.
  • Lincoln SE; Complete Genomics, Inc., Mountain View, California.
  • Ballinger DG; Complete Genomics, Inc., Mountain View, California.
  • Laramie JM; Complete Genomics, Inc., Mountain View, California.
  • Nilsen GB; Complete Genomics, Inc., Mountain View, California.
  • Barber TD; Lilly Corporate Center, Indianapolis, Indiana.
  • Tan P; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore. Genomic Oncology, Duke-NUS Graduate Medical School, Singapore, Singapore. Cancer Science Institute of Singapore, Yong Loo Lin School of Medicine, National University of Singapore, Singapore, Singapore;
  • Hillmer AM; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore. ngpc4@gis.a-star.edu.sg tanbop@gis.a-star.edu.sg hillmer@gis.a-star.edu.sg.
  • Ng PC; Cancer Therapeutics and Stratified Oncology, Genome Institute of Singapore, Singapore, Singapore. ngpc4@gis.a-star.edu.sg tanbop@gis.a-star.edu.sg hillmer@gis.a-star.edu.sg.
Cancer Res ; 74(21): 6071-81, 2014 Nov 01.
Article em En | MEDLINE | ID: mdl-25189529
ABSTRACT
Asian nonsmoking populations have a higher incidence of lung cancer compared with their European counterparts. There is a long-standing hypothesis that the increase of lung cancer in Asian never-smokers is due to environmental factors such as second-hand smoke. We analyzed whole-genome sequencing of 30 Asian lung cancers. Unsupervised clustering of mutational signatures separated the patients into two categories of either all the never-smokers or all the smokers or ex-smokers. In addition, nearly one third of the ex-smokers and smokers classified with the never-smoker-like cluster. The somatic variant profiles of Asian lung cancers were similar to that of European origin with G.C>T.A being predominant in smokers. We found EGFR and TP53 to be the most frequently mutated genes with mutations in 50% and 27% of individuals, respectively. Among the 16 never-smokers, 69% had an EGFR mutation compared with 29% of 14 smokers/ex-smokers. Asian never-smokers had lung cancer signatures distinct from the smoker signature and their mutation profiles were similar to European never-smokers. The profiles of Asian and European smokers are also similar. Taken together, these results suggested that the same mutational mechanisms underlie the etiology for both ethnic groups. Thus, the high incidence of lung cancer in Asian never-smokers seems unlikely to be due to second-hand smoke or other carcinogens that cause oxidative DNA damage, implying that routine EGFR testing is warranted in the Asian population regardless of smoking status.
Assuntos

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poluição por Fumaça de Tabaco / Dano ao DNA / Neoplasias Pulmonares Idioma: En Ano de publicação: 2014 Tipo de documento: Article

Texto completo: 1 Base de dados: MEDLINE Assunto principal: Poluição por Fumaça de Tabaco / Dano ao DNA / Neoplasias Pulmonares Idioma: En Ano de publicação: 2014 Tipo de documento: Article